Terms ending in 2041
Every in-force patent on D. E. Shaw Research, LLC's record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,217,834 | Molecular Graph Generation from Structural Features Using an Artificial Neural Network In force · High confidence | D.E. Shaw Research, LLC | In force | High confidence | |
| US 12,581,252 | SUBSTITUTED PYRROLO[3,4-b]PYRIDINES AS PI3K-ALPHA INHIBITORS In force · High confidence | Relay Therapeutics, Inc. | In force | High confidence | |
| US 12,219,327 | Substituted Isoindolines as PI3K-ALPHA Inhibitors In force · High confidence | Relay Therapeutics, Inc. | In force | High confidence | |
| US 12,138,263 | Pyrazolo[3,4-b]pyrazine SHP2 Phosphatase Inhibitors and Methods of Use Thereof In force · High confidence | Relay Therapeutics, Inc. | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by D. E. Shaw Research, LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.